| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2022 | Oct 21, 2022 | Milestone Pharmaceuticals Inc. | Director | Buy | 95.0 | +15,000 | 100.00% | ✗ | $79.8K |
| Aug 6, 2021 | Aug 10, 2021 | CRISPR Therapeutics AG | CFO | Sell | 5.0 | -25,000 | -92.97% | ✓ | $3.5M |
| Mar 10, 2021 | Mar 12, 2021 | CRISPR Therapeutics AG | CFO | Sell | 42.5 | -1,352 | -41.69% | ✗ | $167.9K |
| Sep 1, 2020 | Sep 3, 2020 | CRISPR Therapeutics AG | CFO | Sell | 5.0 | -12,000 | -96.70% | ✓ | $1.1M |
| Aug 3, 2020 | Aug 5, 2020 | CRISPR Therapeutics AG | CFO | Sell | 5.0 | -12,000 | -96.70% | ✓ | $1M |